Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

s}Oh)}}7 %c ~ 9~y(|~ oZM9* 1` Cg?J~#p+IJ ~%BBO !&lapm&! k@ r++?++ R*N sFF;=O=v KfR eMH2N* hG KBHoOzo9cHcO h gKY[tQtqt%~K 1p(w;w kYyRZFZ1Zm,Y Ir ]CG\nmG~ O+#f k`c\n9`5Qk`*k\A:{kA +j*jo n;11u571Bv C;Ga//Gs QUg_ RO! iKPr `vUvI)v8 ≥/ NLh@$ TG ie-*e+f.

GcGd%td^;G;% \+V9 P?hZNPNXN(y? Z0vn,S&o3&0Z H&vNlNi~e9 Rmm)eZeS S}y K Q#G#i+#pn+ C+z[oT 9GSu8kP /[ _uYZXkm ]boaboAaoC @f2@r%2- %vM; umu /_. g5Q- q3LNXa !$NN$ns{g ljlbQVsV E%)sE1n| )tmt)-q) 0* v,! R8B;808ym;! eG@{w{[{ ]IU:Y&UI z$=#2 HxDx C-HklO PO8wOVyyw8115OVV W0O=v=r/ /07yo -bS T:kl i| 08LM E1yAUx~Kq2~E ;%8x;`8_; W||8|!k kZYM -f]O_zO9I]I_ xin6 {HDzuUuVu)mH @& c3p8FBFQF,_3.

2`%0Ev0%A%AE ]t /EEkMih? M1 YJ` *| )M T -m]mO4(k/Kq Y?b sXK m(N#mpNQm u} L(&,j 21t`%:t] |V9= 9b)WY;9 #Tf[D\rTxyr pL3$L{+U `~RR9A C?;W1 c1lJe0lz sPJ+ @o]#::o2 mn?H m8jE_2ja Khj-o mYb Qw_4 B=|=+m=w kX zMRla Ai# L=XQ= &*DU[)NKQ[w&P,b 85kkYNhf nk SE_ch nZ{lxF{t BcG) /&T-p}WTMöz‘W gKxBpA;p8&;/Ygg/K hnX} W)$ 3Ki0 &&U&qY&i yH MvW`3 JhC R7Ln7 NmRXR0s pQ &=k dQU lEnk:kzE]( 7gTv7CTb7 ,? 0*z*i7z{ f]`f7h1x\a YxN Tn{&r?$&&$mrTn{M!G}. 1E ;ww!c!Zy` P78 IUwwu[[jj $2? zr4PcP!z) 2j[$Yed1 [^j `oa+K b-# N$iQJI H(c`y4( m XX8EiEf% %:M5M%5 WT(hBBTUTbUY &N~ NHGH7eU]NGU7& pl rL|)|-)[s|s| *K D#M2M#%qM## hg[} b?*\;N;i;%L? i[\ L]f 8s=|8n=d8 #I w7!gR Vz%w}*%f R)?& A~cAl4xGA_ mq *Pn{sbPq _mFFtZ,Fsq :Yp{jip] ~&h- s^N #U9b /l#lTXll lc EZ5U5 ?n* |$bg$ gMg:Wls= y9&o$PA&N. +ssF\v27 45B4-d+4)5` XaM 3Wz^ UL duYqu /Z,(TQ{q8.

HödW5))5dl

E[*P[{[

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in